How big is the carbohydrate antigen 199 market?

Global Carbohydrate Antigen 19-9 Market Insights and Forecast to 2028

Code: QYRE-Auto-34N8685

Report

2022-01-05

Pages:114

QYResearch

Description

Table of Content

Tables & Figures

Carbohydrate antigen 19-9 is a tetrasaccharide which is usually attached to O-glycans on the surface of cells. It is known to play a vital role in cell-to-cell recognition processes. It is also a tumor marker used primarily in the management of pancreatic cancer.

Market Analysis and Insights: Global Carbohydrate Antigen 19-9 Market

Due to the COVID-19 pandemic, the global Carbohydrate Antigen 19-9 market size is estimated to be worth US$ 100.5 million in 2022 and is forecast to a readjusted size of US$ 145.9 million by 2028 with a CAGR of 6.4% during the review period.

Fully considering the economic change by this health crisis, ELISA accounting for % of the Carbohydrate Antigen 19-9 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Pancreatic Cancer segment is altered to an % CAGR throughout this forecast period.

Global Carbohydrate Antigen 19-9 main manufactuers include Abbott, Ropv and Ortho Clinical Diagnostics. In terms of the type of Carbohydrate Antigen 19-9, it can be divided into ELISA and CLIA. CLIA is the largest market, with a share over 70%.

Global Carbohydrate Antigen 19-9 Scope and Segment

Carbohydrate Antigen 19-9 market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Carbohydrate Antigen 19-9 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

ELISA

CLIA

Segment by Application

Pancreatic Cancer

Colon Cancer

Stomach Cancer

Others

BY COMPANY

Abbott

Roche

Ortho Clinical Diagnostics

BioMérieux

Fujirebio

KAINOS Laboratories

DiaSorin

Danaher Corporation

Siemens

Tellgen

DIACHA Diagnostics

Sichuan Maccura Biotechnology

Dirui

Chemclin IVD

BY REGION

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

1 Study Coverage

1.1 Carbohydrate Antigen 19-9 Product Introduction

1.2 Market by Type

1.2.1 Global Carbohydrate Antigen 19-9 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 ELISA

1.2.3 CLIA

1.3 Market by Application

1.3.1 Global Carbohydrate Antigen 19-9 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Pancreatic Cancer

1.3.3 Colon Cancer

1.3.4 Stomach Cancer

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Carbohydrate Antigen 19-9 Sales Estimates and Forecasts 2017-2028

2.2 Global Carbohydrate Antigen 19-9 Revenue Estimates and Forecasts 2017-2028

2.3 Global Carbohydrate Antigen 19-9 Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Carbohydrate Antigen 19-9 Sales by Region

2.4.1 Global Carbohydrate Antigen 19-9 Sales by Region (2017-2022)

2.4.2 Global Sales Carbohydrate Antigen 19-9 by Region (2023-2028)

2.5 Global Carbohydrate Antigen 19-9 Revenue by Region

2.5.1 Global Carbohydrate Antigen 19-9 Revenue by Region (2017-2022)

2.5.2 Global Carbohydrate Antigen 19-9 Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Carbohydrate Antigen 19-9 Sales by Manufacturers

3.1.1 Global Top Carbohydrate Antigen 19-9 Manufacturers by Sales (2017-2022)

3.1.2 Global Carbohydrate Antigen 19-9 Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Carbohydrate Antigen 19-9 in 2021

3.2 Global Carbohydrate Antigen 19-9 Revenue by Manufacturers

3.2.1 Global Carbohydrate Antigen 19-9 Revenue by Manufacturers (2017-2022)

3.2.2 Global Carbohydrate Antigen 19-9 Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Carbohydrate Antigen 19-9 Revenue in 2021

3.3 Global Carbohydrate Antigen 19-9 Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Carbohydrate Antigen 19-9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Carbohydrate Antigen 19-9 Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Carbohydrate Antigen 19-9 Sales by Type

4.1.1 Global Carbohydrate Antigen 19-9 Historical Sales by Type (2017-2022)

4.1.2 Global Carbohydrate Antigen 19-9 Forecasted Sales by Type (2023-2028)

4.1.3 Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2017-2028)

4.2 Global Carbohydrate Antigen 19-9 Revenue by Type

4.2.1 Global Carbohydrate Antigen 19-9 Historical Revenue by Type (2017-2022)

4.2.2 Global Carbohydrate Antigen 19-9 Forecasted Revenue by Type (2023-2028)

4.2.3 Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2017-2028)

4.3 Global Carbohydrate Antigen 19-9 Price by Type

4.3.1 Global Carbohydrate Antigen 19-9 Price by Type (2017-2022)

4.3.2 Global Carbohydrate Antigen 19-9 Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Carbohydrate Antigen 19-9 Sales by Application

5.1.1 Global Carbohydrate Antigen 19-9 Historical Sales by Application (2017-2022)

5.1.2 Global Carbohydrate Antigen 19-9 Forecasted Sales by Application (2023-2028)

5.1.3 Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2017-2028)

5.2 Global Carbohydrate Antigen 19-9 Revenue by Application

5.2.1 Global Carbohydrate Antigen 19-9 Historical Revenue by Application (2017-2022)

5.2.2 Global Carbohydrate Antigen 19-9 Forecasted Revenue by Application (2023-2028)

5.2.3 Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2017-2028)

5.3 Global Carbohydrate Antigen 19-9 Price by Application

5.3.1 Global Carbohydrate Antigen 19-9 Price by Application (2017-2022)

5.3.2 Global Carbohydrate Antigen 19-9 Price Forecast by Application (2023-2028)

6 North America

6.1 North America Carbohydrate Antigen 19-9 Market Size by Type

6.1.1 North America Carbohydrate Antigen 19-9 Sales by Type (2017-2028)

6.1.2 North America Carbohydrate Antigen 19-9 Revenue by Type (2017-2028)

6.2 North America Carbohydrate Antigen 19-9 Market Size by Application

6.2.1 North America Carbohydrate Antigen 19-9 Sales by Application (2017-2028)

6.2.2 North America Carbohydrate Antigen 19-9 Revenue by Application (2017-2028)

6.3 North America Carbohydrate Antigen 19-9 Market Size by Country

6.3.1 North America Carbohydrate Antigen 19-9 Sales by Country (2017-2028)

6.3.2 North America Carbohydrate Antigen 19-9 Revenue by Country (2017-2028)

6.3.3 United States

6.3.4 Canada

7 Europe

7.1 Europe Carbohydrate Antigen 19-9 Market Size by Type

7.1.1 Europe Carbohydrate Antigen 19-9 Sales by Type (2017-2028)

7.1.2 Europe Carbohydrate Antigen 19-9 Revenue by Type (2017-2028)

7.2 Europe Carbohydrate Antigen 19-9 Market Size by Application

7.2.1 Europe Carbohydrate Antigen 19-9 Sales by Application (2017-2028)

7.2.2 Europe Carbohydrate Antigen 19-9 Revenue by Application (2017-2028)

7.3 Europe Carbohydrate Antigen 19-9 Market Size by Country

7.3.1 Europe Carbohydrate Antigen 19-9 Sales by Country (2017-2028)

7.3.2 Europe Carbohydrate Antigen 19-9 Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Carbohydrate Antigen 19-9 Market Size by Type

8.1.1 Asia Pacific Carbohydrate Antigen 19-9 Sales by Type (2017-2028)

8.1.2 Asia Pacific Carbohydrate Antigen 19-9 Revenue by Type (2017-2028)

8.2 Asia Pacific Carbohydrate Antigen 19-9 Market Size by Application

8.2.1 Asia Pacific Carbohydrate Antigen 19-9 Sales by Application (2017-2028)

8.2.2 Asia Pacific Carbohydrate Antigen 19-9 Revenue by Application (2017-2028)

8.3 Asia Pacific Carbohydrate Antigen 19-9 Market Size by Region

8.3.1 Asia Pacific Carbohydrate Antigen 19-9 Sales by Region (2017-2028)

8.3.2 Asia Pacific Carbohydrate Antigen 19-9 Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Carbohydrate Antigen 19-9 Market Size by Type

9.1.1 Latin America Carbohydrate Antigen 19-9 Sales by Type (2017-2028)

9.1.2 Latin America Carbohydrate Antigen 19-9 Revenue by Type (2017-2028)

9.2 Latin America Carbohydrate Antigen 19-9 Market Size by Application

9.2.1 Latin America Carbohydrate Antigen 19-9 Sales by Application (2017-2028)

9.2.2 Latin America Carbohydrate Antigen 19-9 Revenue by Application (2017-2028)

9.3 Latin America Carbohydrate Antigen 19-9 Market Size by Country

9.3.1 Latin America Carbohydrate Antigen 19-9 Sales by Country (2017-2028)

9.3.2 Latin America Carbohydrate Antigen 19-9 Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Carbohydrate Antigen 19-9 Market Size by Type

10.1.1 Middle East and Africa Carbohydrate Antigen 19-9 Sales by Type (2017-2028)

10.1.2 Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Type (2017-2028)

10.2 Middle East and Africa Carbohydrate Antigen 19-9 Market Size by Application

10.2.1 Middle East and Africa Carbohydrate Antigen 19-9 Sales by Application (2017-2028)

10.2.2 Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Application (2017-2028)

10.3 Middle East and Africa Carbohydrate Antigen 19-9 Market Size by Country

10.3.1 Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2017-2028)

10.3.2 Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Abbott

11.1.1 Abbott Corporation Information

11.1.2 Abbott Overview

11.1.3 Abbott Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Abbott Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Abbott Recent Developments

11.2 Roche

11.2.1 Roche Corporation Information

11.2.2 Roche Overview

11.2.3 Roche Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Roche Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Roche Recent Developments

11.3 Ortho Clinical Diagnostics

11.3.1 Ortho Clinical Diagnostics Corporation Information

11.3.2 Ortho Clinical Diagnostics Overview

11.3.3 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Ortho Clinical Diagnostics Recent Developments

11.4 BioMérieux

11.4.1 BioMérieux Corporation Information

11.4.2 BioMérieux Overview

11.4.3 BioMérieux Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 BioMérieux Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 BioMérieux Recent Developments

11.5 Fujirebio

11.5.1 Fujirebio Corporation Information

11.5.2 Fujirebio Overview

11.5.3 Fujirebio Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Fujirebio Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Fujirebio Recent Developments

11.6 KAINOS Laboratories

11.6.1 KAINOS Laboratories Corporation Information

11.6.2 KAINOS Laboratories Overview

11.6.3 KAINOS Laboratories Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 KAINOS Laboratories Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 KAINOS Laboratories Recent Developments

11.7 DiaSorin

11.7.1 DiaSorin Corporation Information

11.7.2 DiaSorin Overview

11.7.3 DiaSorin Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 DiaSorin Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 DiaSorin Recent Developments

11.8 Danaher Corporation

11.8.1 Danaher Corporation Corporation Information

11.8.2 Danaher Corporation Overview

11.8.3 Danaher Corporation Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Danaher Corporation Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Danaher Corporation Recent Developments

11.9 Siemens

11.9.1 Siemens Corporation Information

11.9.2 Siemens Overview

11.9.3 Siemens Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Siemens Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Siemens Recent Developments

11.10 Tellgen

11.10.1 Tellgen Corporation Information

11.10.2 Tellgen Overview

11.10.3 Tellgen Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Tellgen Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Tellgen Recent Developments

11.11 DIACHA Diagnostics

11.11.1 DIACHA Diagnostics Corporation Information

11.11.2 DIACHA Diagnostics Overview

11.11.3 DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 DIACHA Diagnostics Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 DIACHA Diagnostics Recent Developments

11.12 Sichuan Maccura Biotechnology

11.12.1 Sichuan Maccura Biotechnology Corporation Information

11.12.2 Sichuan Maccura Biotechnology Overview

11.12.3 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Sichuan Maccura Biotechnology Recent Developments

11.13 Dirui

11.13.1 Dirui Corporation Information

11.13.2 Dirui Overview

11.13.3 Dirui Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.13.4 Dirui Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Dirui Recent Developments

11.14 Chemclin IVD

11.14.1 Chemclin IVD Corporation Information

11.14.2 Chemclin IVD Overview

11.14.3 Chemclin IVD Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2017-2022)

11.14.4 Chemclin IVD Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Chemclin IVD Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Carbohydrate Antigen 19-9 Industry Chain Analysis

12.2 Carbohydrate Antigen 19-9 Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Carbohydrate Antigen 19-9 Production Mode & Process

12.4 Carbohydrate Antigen 19-9 Sales and Marketing

12.4.1 Carbohydrate Antigen 19-9 Sales Channels

12.4.2 Carbohydrate Antigen 19-9 Distributors

12.5 Carbohydrate Antigen 19-9 Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Carbohydrate Antigen 19-9 Industry Trends

13.2 Carbohydrate Antigen 19-9 Market Drivers

13.3 Carbohydrate Antigen 19-9 Market Challenges

13.4 Carbohydrate Antigen 19-9 Market Restraints

14 Key Findings in The Global Carbohydrate Antigen 19-9 Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

Table 1. Global Carbohydrate Antigen 19-9 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of ELISA

Table 3. Major Manufacturers of CLIA

Table 4. Global Carbohydrate Antigen 19-9 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Carbohydrate Antigen 19-9 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Carbohydrate Antigen 19-9 Sales by Region (2017-2022) & (K Doses)

Table 7. Global Carbohydrate Antigen 19-9 Sales Market Share by Region (2017-2022)

Table 8. Global Carbohydrate Antigen 19-9 Sales by Region (2023-2028) & (K Doses)

Table 9. Global Carbohydrate Antigen 19-9 Sales Market Share by Region (2023-2028)

Table 10. Global Carbohydrate Antigen 19-9 Revenue by Region (2017-2022) & (US$ Million)

Table 11. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region (2017-2022)

Table 12. Global Carbohydrate Antigen 19-9 Revenue by Region (2023-2028) & (US$ Million)

Table 13. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region (2023-2028)

Table 14. Global Carbohydrate Antigen 19-9 Sales by Manufacturers (2017-2022) & (K Doses)

Table 15. Global Carbohydrate Antigen 19-9 Sales Share by Manufacturers (2017-2022)

Table 16. Global Carbohydrate Antigen 19-9 Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 17. Global Carbohydrate Antigen 19-9 Revenue Share by Manufacturers (2017-2022)

Table 18. Carbohydrate Antigen 19-9 Price by Manufacturers (2017-2022) &(US$/Dose)

Table 19. Global Carbohydrate Antigen 19-9 Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Carbohydrate Antigen 19-9 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbohydrate Antigen 19-9 as of 2021)

Table 21. Carbohydrate Antigen 19-9 Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Carbohydrate Antigen 19-9 Product Offered

Table 23. Date of Manufacturers Enter into Carbohydrate Antigen 19-9 Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Carbohydrate Antigen 19-9 Sales by Type (2017-2022) & (K Doses)

Table 26. Global Carbohydrate Antigen 19-9 Sales by Type (2023-2028) & (K Doses)

Table 27. Global Carbohydrate Antigen 19-9 Sales Share by Type (2017-2022)

Table 28. Global Carbohydrate Antigen 19-9 Sales Share by Type (2023-2028)

Table 29. Global Carbohydrate Antigen 19-9 Revenue by Type (2017-2022) & (US$ Million)

Table 30. Global Carbohydrate Antigen 19-9 Revenue by Type (2023-2028) & (US$ Million)

Table 31. Global Carbohydrate Antigen 19-9 Revenue Share by Type (2017-2022)

Table 32. Global Carbohydrate Antigen 19-9 Revenue Share by Type (2023-2028)

Table 33. Carbohydrate Antigen 19-9 Price by Type (2017-2022) & (US$/Dose)

Table 34. Global Carbohydrate Antigen 19-9 Price Forecast by Type (2023-2028) & (US$/Dose)

Table 35. Global Carbohydrate Antigen 19-9 Sales by Application (2017-2022) & (K Doses)

Table 36. Global Carbohydrate Antigen 19-9 Sales by Application (2023-2028) & (K Doses)

Table 37. Global Carbohydrate Antigen 19-9 Sales Share by Application (2017-2022)

Table 38. Global Carbohydrate Antigen 19-9 Sales Share by Application (2023-2028)

Table 39. Global Carbohydrate Antigen 19-9 Revenue by Application (2017-2022) & (US$ Million)

Table 40. Global Carbohydrate Antigen 19-9 Revenue by Application (2023-2028) & (US$ Million)

Table 41. Global Carbohydrate Antigen 19-9 Revenue Share by Application (2017-2022)

Table 42. Global Carbohydrate Antigen 19-9 Revenue Share by Application (2023-2028)

Table 43. Carbohydrate Antigen 19-9 Price by Application (2017-2022) & (US$/Dose)

Table 44. Global Carbohydrate Antigen 19-9 Price Forecast by Application (2023-2028) & (US$/Dose)

Table 45. North America Carbohydrate Antigen 19-9 Sales by Type (2017-2022) & (K Doses)

Table 46. North America Carbohydrate Antigen 19-9 Sales by Type (2023-2028) & (K Doses)

Table 47. North America Carbohydrate Antigen 19-9 Revenue by Type (2017-2022) & (US$ Million)

Table 48. North America Carbohydrate Antigen 19-9 Revenue by Type (2023-2028) & (US$ Million)

Table 49. North America Carbohydrate Antigen 19-9 Sales by Application (2017-2022) & (K Doses)

Table 50. North America Carbohydrate Antigen 19-9 Sales by Application (2023-2028) & (K Doses)

Table 51. North America Carbohydrate Antigen 19-9 Revenue by Application (2017-2022) & (US$ Million)

Table 52. North America Carbohydrate Antigen 19-9 Revenue by Application (2023-2028) & (US$ Million)

Table 53. North America Carbohydrate Antigen 19-9 Sales by Country (2017-2022) & (K Doses)

Table 54. North America Carbohydrate Antigen 19-9 Sales by Country (2023-2028) & (K Doses)

Table 55. North America Carbohydrate Antigen 19-9 Revenue by Country (2017-2022) & (US$ Million)

Table 56. North America Carbohydrate Antigen 19-9 Revenue by Country (2023-2028) & (US$ Million)

Table 57. Europe Carbohydrate Antigen 19-9 Sales by Type (2017-2022) & (K Doses)

Table 58. Europe Carbohydrate Antigen 19-9 Sales by Type (2023-2028) & (K Doses)

Table 59. Europe Carbohydrate Antigen 19-9 Revenue by Type (2017-2022) & (US$ Million)

Table 60. Europe Carbohydrate Antigen 19-9 Revenue by Type (2023-2028) & (US$ Million)

Table 61. Europe Carbohydrate Antigen 19-9 Sales by Application (2017-2022) & (K Doses)

Table 62. Europe Carbohydrate Antigen 19-9 Sales by Application (2023-2028) & (K Doses)

Table 63. Europe Carbohydrate Antigen 19-9 Revenue by Application (2017-2022) & (US$ Million)

Table 64. Europe Carbohydrate Antigen 19-9 Revenue by Application (2023-2028) & (US$ Million)

Table 65. Europe Carbohydrate Antigen 19-9 Sales by Country (2017-2022) & (K Doses)

Table 66. Europe Carbohydrate Antigen 19-9 Sales by Country (2023-2028) & (K Doses)

Table 67. Europe Carbohydrate Antigen 19-9 Revenue by Country (2017-2022) & (US$ Million)

Table 68. Europe Carbohydrate Antigen 19-9 Revenue by Country (2023-2028) & (US$ Million)

Table 69. Asia Pacific Carbohydrate Antigen 19-9 Sales by Type (2017-2022) & (K Doses)

Table 70. Asia Pacific Carbohydrate Antigen 19-9 Sales by Type (2023-2028) & (K Doses)

Table 71. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Type (2017-2022) & (US$ Million)

Table 72. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Type (2023-2028) & (US$ Million)

Table 73. Asia Pacific Carbohydrate Antigen 19-9 Sales by Application (2017-2022) & (K Doses)

Table 74. Asia Pacific Carbohydrate Antigen 19-9 Sales by Application (2023-2028) & (K Doses)

Table 75. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Application (2017-2022) & (US$ Million)

Table 76. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Application (2023-2028) & (US$ Million)

Table 77. Asia Pacific Carbohydrate Antigen 19-9 Sales by Region (2017-2022) & (K Doses)

Table 78. Asia Pacific Carbohydrate Antigen 19-9 Sales by Region (2023-2028) & (K Doses)

Table 79. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Region (2017-2022) & (US$ Million)

Table 80. Asia Pacific Carbohydrate Antigen 19-9 Revenue by Region (2023-2028) & (US$ Million)

Table 81. Latin America Carbohydrate Antigen 19-9 Sales by Type (2017-2022) & (K Doses)

Table 82. Latin America Carbohydrate Antigen 19-9 Sales by Type (2023-2028) & (K Doses)

Table 83. Latin America Carbohydrate Antigen 19-9 Revenue by Type (2017-2022) & (US$ Million)

Table 84. Latin America Carbohydrate Antigen 19-9 Revenue by Type (2023-2028) & (US$ Million)

Table 85. Latin America Carbohydrate Antigen 19-9 Sales by Application (2017-2022) & (K Doses)

Table 86. Latin America Carbohydrate Antigen 19-9 Sales by Application (2023-2028) & (K Doses)

Table 87. Latin America Carbohydrate Antigen 19-9 Revenue by Application (2017-2022) & (US$ Million)

Table 88. Latin America Carbohydrate Antigen 19-9 Revenue by Application (2023-2028) & (US$ Million)

Table 89. Latin America Carbohydrate Antigen 19-9 Sales by Country (2017-2022) & (K Doses)

Table 90. Latin America Carbohydrate Antigen 19-9 Sales by Country (2023-2028) & (K Doses)

Table 91. Latin America Carbohydrate Antigen 19-9 Revenue by Country (2017-2022) & (US$ Million)

Table 92. Latin America Carbohydrate Antigen 19-9 Revenue by Country (2023-2028) & (US$ Million)

Table 93. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Type (2017-2022) & (K Doses)

Table 94. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Type (2023-2028) & (K Doses)

Table 95. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Type (2017-2022) & (US$ Million)

Table 96. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Type (2023-2028) & (US$ Million)

Table 97. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Application (2017-2022) & (K Doses)

Table 98. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Application (2023-2028) & (K Doses)

Table 99. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Application (2017-2022) & (US$ Million)

Table 100. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Application (2023-2028) & (US$ Million)

Table 101. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2017-2022) & (K Doses)

Table 102. Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2023-2028) & (K Doses)

Table 103. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (2017-2022) & (US$ Million)

Table 104. Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (2023-2028) & (US$ Million)

Table 105. Abbott Corporation Information

Table 106. Abbott Description and Major Businesses

Table 107. Abbott Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 108. Abbott Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 109. Abbott Recent Developments

Table 110. Roche Corporation Information

Table 111. Roche Description and Major Businesses

Table 112. Roche Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 113. Roche Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Roche Recent Developments

Table 115. Ortho Clinical Diagnostics Corporation Information

Table 116. Ortho Clinical Diagnostics Description and Major Businesses

Table 117. Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 118. Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Ortho Clinical Diagnostics Recent Developments

Table 120. BioMérieux Corporation Information

Table 121. BioMérieux Description and Major Businesses

Table 122. BioMérieux Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 123. BioMérieux Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. BioMérieux Recent Developments

Table 125. Fujirebio Corporation Information

Table 126. Fujirebio Description and Major Businesses

Table 127. Fujirebio Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 128. Fujirebio Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Fujirebio Recent Developments

Table 130. KAINOS Laboratories Corporation Information

Table 131. KAINOS Laboratories Description and Major Businesses

Table 132. KAINOS Laboratories Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 133. KAINOS Laboratories Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. KAINOS Laboratories Recent Developments

Table 135. DiaSorin Corporation Information

Table 136. DiaSorin Description and Major Businesses

Table 137. DiaSorin Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 138. DiaSorin Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. DiaSorin Recent Developments

Table 140. Danaher Corporation Corporation Information

Table 141. Danaher Corporation Description and Major Businesses

Table 142. Danaher Corporation Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 143. Danaher Corporation Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Danaher Corporation Recent Developments

Table 145. Siemens Corporation Information

Table 146. Siemens Description and Major Businesses

Table 147. Siemens Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 148. Siemens Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Siemens Recent Developments

Table 150. Tellgen Corporation Information

Table 151. Tellgen Description and Major Businesses

Table 152. Tellgen Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 153. Tellgen Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. Tellgen Recent Developments

Table 155. DIACHA Diagnostics Corporation Information

Table 156. DIACHA Diagnostics Description and Major Businesses

Table 157. DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 158. DIACHA Diagnostics Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. DIACHA Diagnostics Recent Developments

Table 160. Sichuan Maccura Biotechnology Corporation Information

Table 161. Sichuan Maccura Biotechnology Description and Major Businesses

Table 162. Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 163. Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 164. Sichuan Maccura Biotechnology Recent Developments

Table 165. Dirui Corporation Information

Table 166. Dirui Description and Major Businesses

Table 167. Dirui Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 168. Dirui Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 169. Dirui Recent Developments

Table 170. Chemclin IVD Corporation Information

Table 171. Chemclin IVD Description and Major Businesses

Table 172. Chemclin IVD Carbohydrate Antigen 19-9 Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)

Table 173. Chemclin IVD Carbohydrate Antigen 19-9 Product Model Numbers, Pictures, Descriptions and Specifications

Table 174. Chemclin IVD Recent Developments

Table 175. Key Raw Materials Lists

Table 176. Raw Materials Key Suppliers Lists

Table 177. Carbohydrate Antigen 19-9 Distributors List

Table 178. Carbohydrate Antigen 19-9 Customers List

Table 179. Carbohydrate Antigen 19-9 Market Trends

Table 180. Carbohydrate Antigen 19-9 Market Drivers

Table 181. Carbohydrate Antigen 19-9 Market Challenges

Table 182. Carbohydrate Antigen 19-9 Market Restraints

Table 183. Research Programs/Design for This Report

Table 184. Key Data Information from Secondary Sources

Table 185. Key Data Information from Primary Sources

List of Figures

Figure 1. Carbohydrate Antigen 19-9 Product Picture

Figure 3. Global Carbohydrate Antigen 19-9 Market Share by Type in 2021 & 2028

Figure 3. ELISA Product Picture

Figure 4. CLIA Product Picture

Figure 5. Global Carbohydrate Antigen 19-9 Market Share by Application in 2021 & 2028

Figure 6. Pancreatic Cancer

Figure 7. Colon Cancer

Figure 8. Stomach Cancer

Figure 9. Others

Figure 10. Carbohydrate Antigen 19-9 Report Years Considered

Figure 11. Global Carbohydrate Antigen 19-9 Sales 2017-2028 (K Doses)

Figure 12. Global Carbohydrate Antigen 19-9 Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Carbohydrate Antigen 19-9 Revenue 2017-2028 (US$ Million)

Figure 14. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 15. Global Carbohydrate Antigen 19-9 Sales Market Share by Region (2017-2022)

Figure 16. Global Carbohydrate Antigen 19-9 Sales Market Share by Region (2023-2028)

Figure 17. North America Carbohydrate Antigen 19-9 Sales YoY (2017-2028) & (K Doses)

Figure 18. North America Carbohydrate Antigen 19-9 Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Europe Carbohydrate Antigen 19-9 Sales YoY (2017-2028) & (K Doses)

Figure 20. Europe Carbohydrate Antigen 19-9 Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Asia-Pacific Carbohydrate Antigen 19-9 Sales YoY (2017-2028) & (K Doses)

Figure 22. Asia-Pacific Carbohydrate Antigen 19-9 Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Latin America Carbohydrate Antigen 19-9 Sales YoY (2017-2028) & (K Doses)

Figure 24. Latin America Carbohydrate Antigen 19-9 Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Middle East & Africa Carbohydrate Antigen 19-9 Sales YoY (2017-2028) & (K Doses)

Figure 26. Middle East & Africa Carbohydrate Antigen 19-9 Revenue YoY (2017-2028) & (US$ Million)

Figure 27. The Carbohydrate Antigen 19-9 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 28. The Top 5 and 10 Largest Manufacturers of Carbohydrate Antigen 19-9 in the World: Market Share by Carbohydrate Antigen 19-9 Revenue in 2021

Figure 29. Global Carbohydrate Antigen 19-9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 30. Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2017-2028)

Figure 31. Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2017-2028)

Figure 32. Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2017-2028)

Figure 33. Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2017-2028)

Figure 34. North America Carbohydrate Antigen 19-9 Sales Market Share by Type (2017-2028)

Figure 35. North America Carbohydrate Antigen 19-9 Revenue Market Share by Type (2017-2028)

Figure 36. North America Carbohydrate Antigen 19-9 Sales Market Share by Application (2017-2028)

Figure 37. North America Carbohydrate Antigen 19-9 Revenue Market Share by Application (2017-2028)

Figure 38. North America Carbohydrate Antigen 19-9 Sales Share by Country (2017-2028)

Figure 39. North America Carbohydrate Antigen 19-9 Revenue Share by Country (2017-2028)

Figure 40. United States Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 41. Canada Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 42. Europe Carbohydrate Antigen 19-9 Sales Market Share by Type (2017-2028)

Figure 43. Europe Carbohydrate Antigen 19-9 Revenue Market Share by Type (2017-2028)

Figure 44. Europe Carbohydrate Antigen 19-9 Sales Market Share by Application (2017-2028)

Figure 45. Europe Carbohydrate Antigen 19-9 Revenue Market Share by Application (2017-2028)

Figure 46. Europe Carbohydrate Antigen 19-9 Sales Share by Country (2017-2028)

Figure 47. Europe Carbohydrate Antigen 19-9 Revenue Share by Country (2017-2028)

Figure 48. Germany Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 49. France Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 50. U.K. Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 51. Italy Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 52. Russia Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 53. Asia Pacific Carbohydrate Antigen 19-9 Sales Market Share by Type (2017-2028)

Figure 54. Asia Pacific Carbohydrate Antigen 19-9 Revenue Market Share by Type (2017-2028)

Figure 55. Asia Pacific Carbohydrate Antigen 19-9 Sales Market Share by Application (2017-2028)

Figure 56. Asia Pacific Carbohydrate Antigen 19-9 Revenue Market Share by Application (2017-2028)

Figure 57. Asia Pacific Carbohydrate Antigen 19-9 Sales Share by Region (2017-2028)

Figure 58. Asia Pacific Carbohydrate Antigen 19-9 Revenue Share by Region (2017-2028)

Figure 59. China Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 60. Japan Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 61. South Korea Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 62. India Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 63. Australia Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 64. China Taiwan Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 65. Indonesia Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 66. Thailand Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 67. Malaysia Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 68. Latin America Carbohydrate Antigen 19-9 Sales Market Share by Type (2017-2028)

Figure 69. Latin America Carbohydrate Antigen 19-9 Revenue Market Share by Type (2017-2028)

Figure 70. Latin America Carbohydrate Antigen 19-9 Sales Market Share by Application (2017-2028)

Figure 71. Latin America Carbohydrate Antigen 19-9 Revenue Market Share by Application (2017-2028)

Figure 72. Latin America Carbohydrate Antigen 19-9 Sales Share by Country (2017-2028)

Figure 73. Latin America Carbohydrate Antigen 19-9 Revenue Share by Country (2017-2028)

Figure 74. Mexico Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 75. Brazil Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 76. Argentina Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 77. Middle East and Africa Carbohydrate Antigen 19-9 Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Carbohydrate Antigen 19-9 Revenue Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Carbohydrate Antigen 19-9 Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Carbohydrate Antigen 19-9 Revenue Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Carbohydrate Antigen 19-9 Sales Share by Country (2017-2028)

Figure 82. Middle East and Africa Carbohydrate Antigen 19-9 Revenue Share by Country (2017-2028)

Figure 83. Turkey Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 84. Saudi Arabia Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 85. UAE Carbohydrate Antigen 19-9 Revenue (2017-2028) & (US$ Million)

Figure 86. Carbohydrate Antigen 19-9 Value Chain

Figure 87. Carbohydrate Antigen 19-9 Production Process

Figure 88. Channels of Distribution

Figure 89. Distributors Profiles

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

Global Carbohydrate Antigen 19-9 Market Insights and Forecast to 2028

Published Date: 2022-01-05

Report Code: QYRE-Auto-34N8685

Global Carbohydrate Antigen 19-9 Market Insights and Forecast to 2028

Segment by Type

Segment by Application

BY COMPANY

BY REGION

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions